Finance

Beta
Ask
Lists
GENB:NASDAQ
Generate Biomedicines Inc
14,49 USD
+4,47%
(+0,62) 1D
14,40 USD
-0,62% (-0,090)
After hours
Closed: 18-июн., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GENB...
Open
14,12 USD
High
14,66 USD
Low
13,80 USD
Mkt. cap
1,86 млд
Avg. vol.
776,39 миң
Volume
2,60 млн
52-wk high
16,75 USD
52-wk low
11,00 USD
No. of employees
312
Open
14,12 USD
High
14,66 USD
Low
13,80 USD
Mkt. cap
1,86 млд
Avg. vol.
776,39 миң
Volume
2,60 млн
52-wk high
16,75 USD
52-wk low
11,00 USD
No. of employees
312
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to GENB in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for GENB in the last 3 months.
Highest
Current 14,49 USD
30,00 USD (+107,04%)
Average
25,40 USD (+75,29%)
Lowest
22,00 USD (+51,83%)
News stories
From sources across the web
Profile
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
About Generate Biomedicines Inc
CEO-
Employees312
Founded2018
HeadquartersСомервилл, Массачусетс, Америка Кошмо Штаттары
Sector-
Websitegeneratebiomedicines.com
Last report
2026-ж., 7-май
Fiscal period
Q1 2026
EPS / Est. (USD)
-1,07 USD / -0,51 USD
-111,18%miss
Revenue / Est. (USD)
7,22 млн / 4,75 млн
+52,08%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. мар.
2026-ж. мар.
Revenue
8,82 млн
7,22 млн
Cost of goods sold
46,82 млн
57,81 млн
Cost of revenue
46,82 млн
57,81 млн
Research and development expenses
-
-
Total research and development expenses
-
-
Selling, general, and admin expenses
10,15 млн
13,52 млн
Operating expense
10,15 млн
13,52 млн
Total operating expenses
56,97 млн
71,34 млн
Operating income
-48,15 млн
-64,11 млн
Other non operating income
-
-363,00 миң
EBT including unusual items
-44,26 млн
-61,69 млн
EBT excluding unusual items
-44,26 млн
-61,69 млн
Income tax expense
56,00 миң
28,00 миң
Effective tax rate
-0,13%
-0,05%
Other operating expenses
-
-
Net income
-41,68 млн
-61,45 млн
Net profit margin
-472,73%
-850,58%
Earnings per share
-
-1,07
Interest and investment income
4,28 млн
2,91 млн
Interest expense
-368,00 миң
-182,00 миң
Net interest expenses
3,91 млн
2,73 млн
Depreciation and amortization charges
-
-
EBITDA
-46,84 млн
-63,04 млн
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer